Press Releases

Bank of England

1. Objectives Building on the insights from Project Meridian FX,footnote [1] Project Meridian FX APAC explores synchronisation’s potential to support payment-versus-payment (PvP) settlement across a wider range of currencies, technologies,...

EIN Presswire

Led by financial advisor and retired federal employee Anthony Patton, the free newsletter analyzes the individual TSP funds and the market trends shaping them.

GlobeNewswire, Inc.

DUBAI, United Arab Emirates, Nov. 13, 2026 (GLOBE NEWSWIRE) -- AIBC World was held in Rome from 02 to 05 November, bringing together speakers and delegates to discuss developments in AI, blockchain and digital assets, as well as their impact on...

GlobeNewswire, Inc.

TORONTO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) announced its financial and operating results for the three and nine months ended September 30, 2026. The third quarter of 2026...

GlobeNewswire, Inc.

MONROE TOWNSHIP, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (“OPT” or the “Company”) (NYSE American: OPTT), a leader in intelligent maritime solutions and services, today announced the pricing of its previously...

GlobeNewswire, Inc.

SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce third quarter 2026 financial results on Monday, November 16 after market close.

GlobeNewswire, Inc.

MT. OLIVE, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCID: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the...

GlobeNewswire, Inc.

$100 million license awarded from U.S. Department of Commerce for sale and export of recycled black mass product Major milestone achieved with federal permitting for ABTC’s Tonopah Flats Lithium Project, one of the largest identified critical...

GlobeNewswire, Inc.

Earnings Call Scheduled for 8:00 A.M. U.S. ET on November 18, 2026 JINHUA, China, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (“Kandi” or the “Company”) (NASDAQ GS: KNDI), a global innovator in intelligent equipment and a...

GlobeNewswire, Inc.

Built on approximately $1.7 billion in historical infrastructure investment with estimated replacement value over $3.2 billion.

GlobeNewswire, Inc.

CALGARY, Alberta, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Inventronics Limited (“Corporation”) (IVX: TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada...

GlobeNewswire, Inc.

Expanding scientific rationale for Ampligen® in the evolving pancreatic cancer treatment landscape, including potential complementary approaches with RAS-targeted therapies Ampligen dosing completed in Phase 2 DURIPANC study, positioning Company...

GlobeNewswire, Inc.

Lakewood, NJ, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: XGPU) (“Reliance” or the “Company”) announced today that it will host a conference call on Monday, November 16, 2026, at 4:30 PM Eastern Time to discuss financial...

GlobeNewswire, Inc.

WOBURN, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology,...

GlobeNewswire, Inc.

PRINCETON, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today...

GlobeNewswire, Inc.

Total net revenue increased approximately 9% to $19.2 million for the third quarter of 2026 compared to the third quarter of 2025 Fortress repaid its credit facility in full in September 2026 A subsidiary of Fortress entered into a license...

GlobeNewswire, Inc.

Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients with Oculopharyngeal Muscular Dystrophy (OPMD), presented as a late-breaking poster at the European Society of Gene and Cell Therapy (ESGCT) Annual...

GlobeNewswire, Inc.

Last patient, last visit of the 6-month treatment period in the Phase 3 DUET-AD study is scheduled for December 31, 2026, with database lock on February 8, 2027, and data readout in March 2027 Parkinson’s disease open-label extension (OLE-PD)...

GlobeNewswire, Inc.

Name changed from Quince Therapeutics, Inc. to IRulya Therapeutics Inc.; common stock began trading on the Nasdaq Capital Market under the ticker “IRLA” on October 12, 2026 Phase 2 data in bronchiolitis obliterans syndrome (BOS) post lung...

GlobeNewswire, Inc.

FDA lifted clinical hold on ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS) Meeting with the FDA scheduled for the first quarter of 2027 to discuss the Company’s proposed clinical development plan for ARD-101; Company...